CJC-1295 DAC has shown some amazing results as a growth hormone
releasing hormone (GHRH) analog. Not only has CJC-1295 shown the
ability to increase growth hormone and IGF-I secretion and its
benefits, but it has been able to do so in very large amounts.
Recent research studies have shown that CJC - 1295 stimulates GH
and IGF-1 Secretion, and will keep a steady increase of HGH and
IGF-1 with no increase in prolactin, leading to intense fat loss,
and increases protein synthesis.
CJC-1295 is a long-acting GHRH analog and stimulates GH and IGF-1
secretion. It will keep a steady increase of HGH and IGF-1 with no
increase in prolactin.  CJC-1295 represents a very exciting new
compound that has the potential to increase growth hormone and
IGF-I secretion and effects, with a built-in safeguard (the
feedback effects of IGF-I) to limit excessive elevations of GH and
IGF-1 levels. Intense fat loss. Increases protein synthesis for
more muscle growth. GHRHKO animals receiving daily doses of
CJC-1295 exhibited normal body weight and length. Mice treated
every 48 and 72 h reached higher body weight and length than
placebo-treated animals, without full growth normalization.
|Product Name:||cjc 1295/cjc dac 1295|
More Peptides Series
|CJC-1295 with DAC||2mg/vial|
|CJC-1295 without DAC||2mg/vial|